ReviewFrontiers in genetics2019
Bayesian Inference for Mixed Model-Based Genome-Wide Analysis of Expression Quantitative Trait Loci by Gibbs Sampling.
Review in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deciphering the Genetic Complexity of Classical Hodgkin Lymphoma: Insights and Effective Strategies.Current genomics · 2024Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The importance of expression quantitative trait locus (eQTL) has been emphasized in understanding the genetic basis of cellular activities and complex phenotypes. Mixed models can be employed to effectively identify eQTLs by explaining polygenic effects. In these mixed models, the polygenic effects are considered as random variables, and their variability is explained by the polygenic variance component. The polygenic and residual variance components are first estimated, and then eQTL effects are estimated depending on the variance component estimates within the frequentist mixed model framework. The Bayesian approach to the mixed model-based genome-wide eQTL analysis can also be applied to estimate the parameters that exhibit various benefits. Bayesian inferences on unknown parameters are based on their marginal posterior distributions, and the marginalization of the joint posterior distribution is a challenging task. This problem can be solved by employing a numerical algorithm of integrals called Gibbs sampling as a Markov chain Monte Carlo. This article reviews the mixed model-based Bayesian eQTL analysis by Gibbs sampling. Theoretical and practical issues of Bayesian inference are discussed using a concise description of Bayesian modeling and the corresponding Gibbs sampling. The strengths of Bayesian inference are also discussed. Posterior probability distribution in the Bayesian inference reflects uncertainty in unknown parameters. This factor is useful in the context of eQTL analysis where a sample size is too small to apply the frequentist approach. Bayesian inference based on the posterior that reflects prior knowledge, will be increasingly preferred with the accumulation of eQTL data. Extensive use of the mixed model-based Bayesian eQTL analysis will accelerate understanding of eQTLs exhibiting various regulatory functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.